Parker Waichman LLP

Drug Trial Fraud and Misconduct Hidden from Journal Publishers and Public

A study of internal documents from the Food and Drug Administration (FDA) reveals that though the agency has taken action against clinical trials for “significant departures from good clinical practice” and even falsifications, there is no mention of such problems in the published studies. The documents were uncovered through freedom-of-information requests from Charles Seife, a […]

Fraud & Misconduct Hidden from Journal Publishers & Public

Fraud & Misconduct Hidden from Journal Publishers & Public

A study of internal documents from the Food and Drug Administration (FDA) reveals that though the agency has taken action against clinical trials for “significant departures from good clinical practice” and even falsifications, there is no mention of such problems in the published studies.

The documents were uncovered through freedom-of-information requests from Charles Seife, a professor at the Arthur L. Carter Institute of Journalism at New York University. Seife and his students cross-referenced FDA’s actions against available published peer-reviewed studies. Their results are published in the most recent online issue of JAMA Internal Medicine, Medical News Today reports.

The group found bad practices ranging from falsification of results to poor record keeping in the 57 trials that received action between 1998 and 2013. “Official action indicated” (OAI) is the FDA’s most severe form of clinical trial violation. In the 2013 fiscal year, Seife reports, about 2 percent of the FDA’s 644 inspections at trial sites were classified OAI. A study published in 2012, for example, makes positive claims about a stem cell treatment for 26 patients with severe loss of blood circulation to their legs. The study cited “major clinical improvements” for all, but did not mention that one patient had the leg amputated two weeks after the treatment. The FDA took action but Seife found no correction or retraction of the published results. In another case, the FDA deemed an entire study unreliable but the study was published with no mention of the issue, according to Medical News Today.

An editorial accompanying Seife’s article called such examples “disturbing.” Dr. Robert Steinbrook and Dr. Rita Redberg say a “central responsibility of medical journals is maintaining and improving trust in the medical literature.” Investigators and sponsors of clinical trials should notify journals of substantial findings from regulatory agency inspections, and “modify their reports of clinical trials as needed, either before or after publication,” Medical News Today reports.

Seife concluded that significant FDA findings are seldom revealed in peer-reviewed literature, even when there is “evidence of data fabrication or other forms of research misconduct.” The FDA does not typically notify journals when a clinical trial site receives an OAI inspection, nor does it generally alert the public about the research misconduct it finds. Heavy redaction of released FDA documents makes it “very difficult, or even impossible, to determine which published clinical trials are implicated by the FDA’s allegations of research misconduct,” according to Medical News Today.

 

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Love the way Ms Asia Gali was very attentive and so polite when i called to ask about there services and she made sure to call me back when needed to or text to make sure my appointment with them was on time and set on schedule! She was Great! Thank you so much Asia from Parker Waichman LLP! You guys are the best and definitely will recommend you to anyone in need! — Robert Pombo Jr.
Robert Pombo
11 months ago
5 Star Reviews 150
It was a pleasure speaking with Ms. Josama. I really like how she made my grandmother feel safe and secure and make a decision. Thank you.
Matt Smart
4 years ago
5 Star Reviews 150
I am a 9/11 survivor and it was my good fortune to work with paralegal Benita Rollis. She thoroughly explained the process and helped me to complete all the paperwork. I distinctly remember the day she called to check on me and to encourage me to schedule a medical appointment with WTC health program. I was reluctant to proceed but Benita gave me a much needed pep talk. Thank you Benita! All of Benita’s hard work has made the difference and this has been concluded very favorably.
FredHart
2 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038